Stakeholder Perspectives on CMS’s 2022 Notice of Benefit and Payment Parameters. Part 2: State Insurance Departments and Marketplaces

In one of the Trump administration’s last acts, the Centers for Medicare and Medicaid Services finalized some of the major provisions of the 2022 Notice of Benefit and Payment Parameters. In the second part of our blog series reviewing stakeholder comments, CHIR’s Rachel Schwab takes a look at how state insurance departments and state-based marketplaces responded to some of the recently finalized proposals. Continue reading

The Final 2021 Notice of Benefit and Payment Parameters: Implications for States

The Trump administration has released the annual rule governing insurance standards and marketplace operations under the Affordable Care Act. In an Expert Perspective for the Robert Wood Johnson Foundation’s State Health & Value Strategies project, Sabrina Corlette assesses the implications for state insurance regulation and the state-based marketplaces. Continue reading

Stakeholders React to HHS’s Notice of Benefit and Payment Parameters for 2020. Part 3: Consumer Advocates

On April 18, 2019, the Department of Health and Human Services finalized changes to the Affordable Care Act marketplaces and insurance rules in the Notice of Benefit and Payment Parameters for the 2020 plan year. To gauge stakeholder reactions, CHIR reviewed a sample of these comments. In the third and final of our blog series, CHIR’s Olivia Hoppe summarizes responses from a selection of consumer advocates. Continue reading

Stakeholders React to HHS’s Notice of Benefit and Payment Parameters for 2020. Part 1: Insurers

On January 18, the Department of Health and Human Services issued its Notice of Benefit and Payment Parameters for 2020, which outlines the changes that it plans to apply to the Affordable Care Act marketplaces and insurance rules in the next plan year. The agency received over 26,100 comments on the proposal, including many from insurers, state-based marketplaces, departments of insurance, and consumer advocates. To better understand stakeholder reactions to the proposals, CHIR reviewed a sample of these comments, and, in Part I of this series, we summarize areas of support and concern from major medical insurers and associations. Continue reading